A detailed history of Pictet & Cie (Europe) Sa transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 223,000 shares of SOPH stock, worth $726,980. This represents 0.02% of its overall portfolio holdings.

Number of Shares
223,000
Previous 223,000 -0.0%
Holding current value
$726,980
Previous $1.02 Million 20.37%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$4.21 - $5.62 $19,366 - $25,852
-4,600 Reduced 2.02%
223,000 $1.1 Million
Q1 2022

May 04, 2022

BUY
$7.31 - $15.6 $1.66 Million - $3.55 Million
227,600 New
227,600 $1.76 Million

Others Institutions Holding SOPH

About SOPHiA GENETICS SA


  • Ticker SOPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 64,153,700
  • Market Cap $209M
  • Description
  • SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...
More about SOPH
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.